C J Currie

Summary

Affiliation: Cardiff University
Country: UK

Publications

  1. ncbi Estimation of health-related utility (EQ-5D index) in subjects with seasonal allergic rhinoconjunctivitis to evaluate health gain associated with sublingual grass allergen immunotherapy
    Chris D Poole
    Cochrane Institute of Primary Care and Public Health, Cardiff University, Cardiff, Wales, UK
    Health Qual Life Outcomes 12:99. 2014
  2. pmc Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin
    Sarah E Holden
    Department of Pharmacoepidemiology and Pharmacoeconomics, Pharmatelligence, Cardiff Medicentre, Cardiff, UK
    BMJ Open 1:e000258. 2011
  3. doi External validation of the UKPDS risk engine in incident type 2 diabetes: a need for new type 2 diabetes-specific risk equations
    Christian A Bannister
    Corresponding author Craig J Currie
    Diabetes Care 37:537-45. 2014
  4. ncbi Treatment of rheumatoid arthritis with etanercept with reference to disease-modifying anti-rheumatic drugs: long-term safety and survival using prospective, observational data
    Christopher Ll Morgan
    Pharma Research Centre, Cardiff Medicentre, School of Medicine, Institute of Primary Care and Public Health, Cardiff University, Cardiff CF14 4UJ, UK
    Rheumatology (Oxford) 53:186-94. 2014
  5. doi The impact of treatment non-compliance on mortality in people with type 1 diabetes
    Craig J Currie
    Department of Medicine, School of Medicine, Cardiff University, Cardiff, UK
    J Diabetes Complications 27:219-23. 2013
  6. pmc Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes
    Craig J Currie
    School of Medicine, Cardiff University, The Pharma Research Centre, Cardiff Medicentre, Cardiff CF14 4UJ, United Kingdom
    J Clin Endocrinol Metab 98:668-77. 2013
  7. doi What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes
    Christopher Ll Morgan
    Department of Primary Care and Public Health, School of Medicine, Cardiff University, Cardiff CF14 4UJ, United Kingdom
    J Clin Endocrinol Metab 97:4605-12. 2012
  8. pmc The impact of treatment noncompliance on mortality in people with type 2 diabetes
    Craig J Currie
    Department of Medicine, School of Medicine, Cardiff University, Cardiff, Wales, U K
    Diabetes Care 35:1279-84. 2012
  9. pmc Deriving health state utilities for the numerical pain rating scale
    Simon Dixon
    School of Health and Related Research, University of Sheffield, UK
    Health Qual Life Outcomes 9:96. 2011
  10. pmc The association between C-reactive protein and the likelihood of progression to joint replacement in people with rheumatoid arthritis: a retrospective observational study
    Chris D Poole
    360o Research Limited, Penarth, UK
    BMC Musculoskelet Disord 9:146. 2008

Detail Information

Publications59

  1. ncbi Estimation of health-related utility (EQ-5D index) in subjects with seasonal allergic rhinoconjunctivitis to evaluate health gain associated with sublingual grass allergen immunotherapy
    Chris D Poole
    Cochrane Institute of Primary Care and Public Health, Cardiff University, Cardiff, Wales, UK
    Health Qual Life Outcomes 12:99. 2014
    ....
  2. pmc Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin
    Sarah E Holden
    Department of Pharmacoepidemiology and Pharmacoeconomics, Pharmatelligence, Cardiff Medicentre, Cardiff, UK
    BMJ Open 1:e000258. 2011
    ..Conclusion Given the high marginal cost of analogue insulin, adherence to prescribing guidelines recommending the preferential use of human insulin would have resulted in considerable financial savings over the period...
  3. doi External validation of the UKPDS risk engine in incident type 2 diabetes: a need for new type 2 diabetes-specific risk equations
    Christian A Bannister
    Corresponding author Craig J Currie
    Diabetes Care 37:537-45. 2014
    ..To evaluate the performance of the UK Prospective Diabetes Study Risk Engine (UKPDS-RE) for predicting the 10-year risk of cardiovascular disease end points in an independent cohort of U.K. patients newly diagnosed with type 2 diabetes...
  4. ncbi Treatment of rheumatoid arthritis with etanercept with reference to disease-modifying anti-rheumatic drugs: long-term safety and survival using prospective, observational data
    Christopher Ll Morgan
    Pharma Research Centre, Cardiff Medicentre, School of Medicine, Institute of Primary Care and Public Health, Cardiff University, Cardiff CF14 4UJ, UK
    Rheumatology (Oxford) 53:186-94. 2014
    ..The objective of this study was to examine the long-term safety of etanercept (ETN) in comparison with conventional DMARDs in a large observational cohort of RA patients in the UK...
  5. doi The impact of treatment non-compliance on mortality in people with type 1 diabetes
    Craig J Currie
    Department of Medicine, School of Medicine, Cardiff University, Cardiff, UK
    J Diabetes Complications 27:219-23. 2013
    ..To determine if a diagnostic record of poor treatment compliance (medication non-compliance and/or non-attendance at medical appointments) was associated with all-cause mortality in people with type 1 diabetes...
  6. pmc Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes
    Craig J Currie
    School of Medicine, Cardiff University, The Pharma Research Centre, Cardiff Medicentre, Cardiff CF14 4UJ, United Kingdom
    J Clin Endocrinol Metab 98:668-77. 2013
    ..The safety of insulin in the treatment of type 2 diabetes mellitus (T2DM) has recently undergone scrutiny...
  7. doi What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes
    Christopher Ll Morgan
    Department of Primary Care and Public Health, School of Medicine, Cardiff University, Cardiff CF14 4UJ, United Kingdom
    J Clin Endocrinol Metab 97:4605-12. 2012
    ..After failure of metformin monotherapy, many second-line, glucose-lowering therapies are available to treat people with type 2 diabetes...
  8. pmc The impact of treatment noncompliance on mortality in people with type 2 diabetes
    Craig J Currie
    Department of Medicine, School of Medicine, Cardiff University, Cardiff, Wales, U K
    Diabetes Care 35:1279-84. 2012
    ..To assess the association of compliance with treatment (medication and clinic appointments) and all-cause mortality in people with insulin-treated type 2 diabetes...
  9. pmc Deriving health state utilities for the numerical pain rating scale
    Simon Dixon
    School of Health and Related Research, University of Sheffield, UK
    Health Qual Life Outcomes 9:96. 2011
    ..This study derived utility values for a series of EQ-5D health states that replace the pain dimensions with the NPRS, thereby allowing a potentially greater range of pain intensities to be captured and included in economic analyses...
  10. pmc The association between C-reactive protein and the likelihood of progression to joint replacement in people with rheumatoid arthritis: a retrospective observational study
    Chris D Poole
    360o Research Limited, Penarth, UK
    BMC Musculoskelet Disord 9:146. 2008
    ....
  11. pmc Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival
    Craig J Currie
    Department of Primary Care and Public Health, School ofMedicine, Cardiff University, Cardiff, UK
    Diabetes Care 35:299-304. 2012
    ..We examined the hypotheses that survival after a diagnosis of solid-tumor cancer is reduced in those with diabetes when compared with those without diabetes, and that treatment with metformin influences survival after cancer diagnosis...
  12. doi An overview and commentary on retrospective, continuous glucose monitoring for the optimisation of care for people with diabetes
    Craig J Currie
    Department of Medicine, School of Medicine, Cardiff University, Cardiff Medicentre, CF14 1UJ, UK
    Curr Med Res Opin 25:2389-400. 2009
    ....
  13. doi Dispensing patterns and financial costs of glucose-lowering therapies in the UK from 2000 to 2008
    C J Currie
    Department of Medicine, School of Medicine, Cardiff University, The Pharma Research Centre, Cardiff Medicentre, Cardiff, Wales, UK
    Diabet Med 27:744-52. 2010
    ..A variety of influences determine prescribing behaviour. The purpose of this study was to characterize the pattern of dispensing for glucose-lowering and monitoring in the UK from 2000 to 2008, inclusively...
  14. ncbi Estimation of primary care treatment costs and treatment efficacy for people with Type 1 and Type 2 diabetes in the United Kingdom from 1997 to 2007*
    C J Currie
    Department of Medicine, School of Medicine, Cardiff University, Cardiff, UK
    Diabet Med 27:938-48. 2010
    ..The purpose of this study was to characterize the financial cost and efficacy of primary care treatment for diabetes in the United Kingdom from 1997 to 2007...
  15. doi The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
    C J Currie
    School of Medicine, Cardiff University, The Pharma Research Centre, Cardiff Medicentre, Cardiff, CF14 4UJ, UK
    Diabetologia 52:1766-77. 2009
    ..We examined the risk of development of solid tumours in relation to treatment with oral agents, human insulin and insulin analogues...
  16. ncbi The health-related utility and health-related quality of life of hospital-treated subjects with type 1 or type 2 diabetes with particular reference to differing severity of peripheral neuropathy
    C J Currie
    Department of Medicine, School of Medicine, Cardiff University, Cardiff, UK
    Diabetologia 49:2272-80. 2006
    ..We characterised symptom severity of diabetic peripheral neuropathy (DPN) in people with diabetes, and correlated this with health-related utility and health-related quality of life...
  17. doi The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern
    C J Currie
    School of Medicine, Cardiff University, Cardiff, UK
    Diabetes Obes Metab 14:1-4. 2012
    ..There is no doubt about the value of exogenous insulin for people with type 1 diabetes. The purpose of this commentary is to discuss emerging evidence that this may not be the case for the majority of people with type 2 diabetes...
  18. ncbi The financial costs of hospital care for people with diabetes who have single and multiple macrovascular complications
    Craig J Currie
    Department of Medicine, University Hospital of Wales, Cardiff, Wales CF4 4UJ, UK
    Diabetes Res Clin Pract 67:144-51. 2005
    ..To evaluate the impact on hospital costs of patients being diagnosed with multiple complications of diabetes...
  19. ncbi The financial costs of healthcare treatment for people with Type 1 or Type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy
    C J Currie
    Pharma Researh Centre, University Hospital of Wales, Cardiff, UK
    Diabet Med 24:187-94. 2007
    ..To characterize symptom severity of diabetic peripheral neuropathy (DPN) in people with diabetes and to characterize its association with healthcare resource use...
  20. ncbi Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality
    C J Currie
    Department of Medicine, School of Medicine, Cardiff University, Cardiff, UK
    Heart 94:457-62. 2008
    ....
  21. doi Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study
    Craig J Currie
    Department of Medicine, School of Medicine, Cardiff University, Cardiff, UK
    Lancet 375:481-9. 2010
    ..Results of intervention studies in patients with type 2 diabetes have led to concerns about the safety of aiming for normal blood glucose concentrations. We assessed survival as a function of HbA(1c) in people with type 2 diabetes...
  22. doi Quality of life and health-related utility analysis of adults with moderate and severe atopic dermatitis treated with tacrolimus ointment vs. topical corticosteroids
    C D Poole
    Department of Epidemiology, Pharmatelligence Ltd, Cardiff, UK
    J Eur Acad Dermatol Venereol 24:674-8. 2010
    ....
  23. ncbi Characterization and comparison of health-related utility in people with diabetes with various single and multiple vascular complications
    C Ll Morgan
    Department of Medicine, School of Medicine, Cardiff University, Cardiff, UK
    Diabet Med 23:1100-5. 2006
    ..To characterize and compare health-related utility in a large cohort of patients treated in hospital with diabetes and with single and multiple comorbidities...
  24. pmc Evaluation of survival and ischaemic and thromboembolic event rates in patients with non-valvar atrial fibrillation in the general population when treated and untreated with warfarin
    C J Currie
    School of Medicine, Cardiff University, Cardiff, UK
    Heart 92:196-200. 2006
    ..To compare survival and adverse outcome of patients with non-valvar atrial fibrillation (NVAF) treated with or without warfarin...
  25. doi The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010
    S H Holden
    Department of Primary Care and Public Health, School of Medicine, Cardiff University, The Pharma Research Centre, Cardiff Medicentre, Cardiff, UK
    Diabetes Obes Metab 15:844-52. 2013
    ..To characterize the incidence of type 2 diabetes in the UK over the previous 20 years; and determine if there has been an increase in people aged 40 years or less at diagnosis...
  26. ncbi Evaluation of the cost-effectiveness of sirolimus versus cyclosporin for immunosuppression after renal transplantation in the United Kingdom
    Phil McEwan
    School of Mathematics, Cardiff University, Cardiff, Wales, United Kingdom
    Clin Ther 27:1834-46. 2005
    ....
  27. doi An evaluation of the association between C-reactive protein, the change in C-reactive protein over one year, and all-cause mortality in chronic immune-mediated inflammatory disease managed in UK general practice
    C D Poole
    Pharmatelligence, Medicentre, University Hospital of Wales, Cardiff, UK
    Rheumatology (Oxford) 48:78-82. 2009
    ..To also evaluate the association between change in CRP status (sub-acute, < or =10 mg/l and acute >10 mg/l) and all-cause mortality...
  28. doi Weight change in people with type 2 diabetes: secular trends and the impact of alternative antihyperglycaemic drugs
    C Ll Morgan
    Department of Epidemiology, Pharmatelligence, Cardiff, UK
    Diabetes Obes Metab 14:424-32. 2012
    ..This study aimed to describe the pattern of weight change in people with type 2 diabetes (T2DM) over time and when using alternative treatment regimens...
  29. doi Estimated costs of acute hospital care for people with diabetes in the United Kingdom: a routine record linkage study in a large region
    C Ll Morgan
    Department of Epidemiology, Pharmatelligence, Cardiff, UK
    Diabet Med 27:1066-73. 2010
    ..Diabetes represents a notable burden to health payers. The purpose of this study was to estimate acute hospital care costs of treating people with diabetes with reference to the costs of treating those without...
  30. ncbi Evaluation of a hospital diabetes specialist nursing service: a randomized controlled trial
    M Davies
    Department of Medicine, University Hospital of Wales, Heath Park, Cardiff, Wales, UK
    Diabet Med 18:301-7. 2001
    ..There was no evidence of an adverse effect of reduced LOS on re-admissions, use of community resources, or patient perception of quality of care...
  31. ncbi Relative activity and referral patterns for diabetes and non-diabetes in general practice
    C L Morgan
    Department of Medicine, University Hospital of Wales, Cardiff, UK
    Diabet Med 17:230-5. 2000
    ..To describe and compare general practice (GP) activity for patients with and without diabetes using a survey of general practices representing over 10% of the Welsh population...
  32. ncbi The changing prevalence of diagnosed diabetes and its associated vascular complications in a large region of the UK
    C L Morgan
    Department of Epidemiology, Cardiff Research Consortium, Cardiff, UK
    Diabet Med 27:673-8. 2010
    ..To characterize the prevalence of diabetes in a large health district in 2004 and compare it with a previous estimate made in 1996...
  33. pmc Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population
    M Jones
    School of Mathematics, Cardiff University, Cardiff, UK
    Heart 91:472-7. 2005
    ..0-3.0 and to explore the relation between achieved INR control and clinical outcomes...
  34. ncbi Evaluation of the association between the EQ-5D (health-related utility) and body mass index (obesity) in hospital-treated people with Type 1 diabetes, Type 2 diabetes and with no diagnosed diabetes
    A J Lee
    Cardiff Research Consortium, University Hospital of Wales, Cardiff CF14 4UJ, Wales, UK
    Diabet Med 22:1482-6. 2005
    ..The purpose of this study was to characterize the impact of body mass index (BMI) on health-related utility for patients with Type 1 and Type 2 diabetes and those without diabetes...
  35. ncbi The routine collation of health outcomes data from hospital treated subjects in the Health Outcomes Data Repository (HODaR): descriptive analysis from the first 20,000 subjects
    Craig J Currie
    Cardiff Research Consortium, University Hospital of Wales, Heath Park, Cardiff, UK
    Value Health 8:581-90. 2005
    ..A new resource, the Health Outcomes Data Repository (HODaR), is described and evaluated for its use in the pharmaceutical research and development process...
  36. ncbi Comparative estimates of the financial burden to the UK health system of hospital care for people with and without diabetes in the year before death
    Craig J Currie
    Department of Diabetes, Endocrinology and Metabolism, University of Wales College of Medicine, Medicentre, Heath Park, Cardiff CF4 4UJ, Wales, UK
    Diabetes Res Clin Pract 65:267-74. 2004
    ..To quantify hospital costs prior to death for patients with and without diabetes...
  37. ncbi Anticoagulation in patients with non-valvular atrial fibrillation: an evaluation of stability and early factors that predict longer-term stability on warfarin in a large UK population
    Craig J Currie
    Department of Medicine, School of Medicine, Cardiff University, Cardiff, UK
    Curr Med Res Opin 21:1905-13. 2005
    ..To then evaluate any associations between stability and outcome and to determine whether stability can be predicted by clinical factors at an early stage in warfarin treatment...
  38. ncbi Evaluation of the cost effectiveness of sirolimus versus tacrolimus for immunosuppression following renal transplantation in the UK
    Phil McEwan
    School of Mathematics, Cardiff University, Cardiff, Wales, UK
    Pharmacoeconomics 24:67-79. 2006
    ..The purpose of this study was to evaluate the relative cost utility of sirolimus versus tacrolimus for the primary prevention of graft rejection in renal transplant recipients in the UK...
  39. ncbi The impact of the overactive bladder on health-related utility and quality of life
    Craig J Currie
    Department of Medicine, School of Medicine, Cardiff University, Cardiff, UK
    BJU Int 97:1267-72. 2006
    ..To evaluate the impact of the overactive bladder (OAB) on quality of life and health-related utility...
  40. ncbi Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes
    Craig J Currie
    Department of Medicine, School of Medicine, Cardiff University, Cardiff, UK
    Curr Med Res Opin 22:1523-34. 2006
    ..The aim was to statistically model the degree of fear of hypoglycaemia experienced by people with diabetes, and then model the resulting change in health-related utility associated with differing severity and frequency of hypoglycaemia...
  41. ncbi How many people inject insulin? UK estimates from 1991 to 2010
    S E Holden
    Cochrane Institute of Primary Care and Public Health, School of Medicine, Cardiff University, The Pharma Research Centre, Cardiff Medicentre, Cardiff, UK
    Diabetes Obes Metab 16:553-9. 2014
    ..We set out to estimate the prevalence rate of insulin use in the UK population, the total number of people in the UK who use insulin, the proportion of users with type 1 and type 2 diabetes and changes between 1991 and 2010...
  42. doi Health-related utility among adults with atopic dermatitis treated with 0.1% tacrolimus ointment as maintenance therapy over the long term: findings from the Protopic CONTROL study
    C D Poole
    Pharmatelligence Ltd, Cardiff, U K
    Br J Dermatol 161:1335-40. 2009
    ..1% tacrolimus ointment for the prevention of flares has been demonstrated to be well tolerated and effective in adults for the treatment of atopic dermatitis (AD) but its impact on health-related utility has not been reported...
  43. ncbi Evaluating the performance of the Framingham risk equations in a population with diabetes
    P McEwan
    School of Mathematics, Cardiff University, Cardiff, UK
    Diabet Med 21:318-23. 2004
    ..The purpose of this study was to evaluate the reliability of these equations in predicting CHD risk in people with diabetes and the reliability of using imputed mean HDL-cholesterol values...
  44. ncbi Characterisation and comparison of health-related quality of life for patients with renal failure
    Amanda J Lee
    Cardiff Research Consortium, University Hospital of Wales, Cardiff, UK
    Curr Med Res Opin 21:1777-83. 2005
    ....
  45. ncbi Pulse pressure predicts cardiovascular risk in patients with type 2 diabetes mellitus
    John R Cockcroft
    Department of Cardiology, University of Wales College of Medicine, University Hospital, Cardiff, Wales
    Am J Hypertens 18:1463-7; discussion 1468-9. 2005
    ..Whether this is also true in subjects with type 2 diabetes, who are at increased risk for cardiovascular disease, is unknown...
  46. ncbi Patterns of graft and patient survival following renal transplantation and evaluation of serum creatinine as a predictor of survival: a review of data collected from one clinical centre over 34 years
    Phil McEwan
    School of Mathematics, Cardiff University, Cardiff, UK
    Curr Med Res Opin 21:1793-800. 2005
    ..The purpose of this study was therefore to characterise the pattern of renal transplantation from 1967 to 2000, focusing on renal graft function as a predictor of survival...
  47. ncbi Evaluation of the costs and outcomes from changes in risk factors in type 2 diabetes using the Cardiff stochastic simulation cost-utility model (DiabForecaster)
    Phil McEwan
    School of Mathematics, Cardiff University, Cardiff, Wales, UK
    Curr Med Res Opin 22:121-9. 2006
    ....
  48. ncbi Should we routinely measure a proxy for insulin resistance as well as improve our modelling techniques to better predict the likelihood of coronary heart disease in people with type 2 diabetes? For debate
    Marc Evans
    Department of Endocrinology, Diabetes and Metabolism, University of Wales College of Medicine, Cardiff, Wales, UK
    Diabetes Obes Metab 6:299-307. 2004
  49. ncbi An economic evaluation of vasoactive agents used in the United Kingdom for acute bleeding oesophageal varices in patients with liver cirrhosis
    Jaroslaw Wechowski
    Cardiff Research Consortium, University Hospital of Wales, Cardiff, UK
    Curr Med Res Opin 23:1481-91. 2007
    ..To conduct an economic evaluation of terlipressin, octreotide and placebo in the treatment of bleeding oesophageal varices (BOV) where endotherapy could be used concomitantly...
  50. pmc Let cost effectiveness models be open to scrutiny
    Chris Poole
    BMJ 335:735. 2007
  51. ncbi Comments on Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin-naïve type 2 diabetes patients: cost-effectiveness analysis in the UK setting
    Craig J Currie
    Curr Med Res Opin 22:967-9; author reply 968-9. 2006
  52. pmc Ischaemic heart disease in men
    Craig J Currie
    Heart 93:1471; author reply 1471-2. 2007
  53. ncbi Economic analysis of the implementation of autologous transfusion technologies throughout England
    Simon Dixon
    School of Health and Related Research, University of Sheffield, South Yorkshire, UK
    Int J Technol Assess Health Care 21:234-9. 2005
    ..This study aims to provide the first estimates of the costs and effects of the large scale introduction of autologous transfusion technologies into the United Kingdom National Health Service...
  54. ncbi Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes
    Ruth E Davis
    School of Care Sciences, University of Glamorgan, Pontypridd, Wales, United Kingdom
    Curr Med Res Opin 21:1477-83. 2005
    ..To characterise the impact of increasing severity and frequency of hypoglycaemia on utility, quality of life, primary care resource use and productivity (time away from normal activities) in people with both Type 1 and Type 2 diabetes...
  55. ncbi An evaluation of the association between systemic inflammation--as measured by C-reactive protein--and hospital resource use
    Chris D Poole
    360 Degree Research Limited, Penarth, UK
    Curr Med Res Opin 23:2785-92. 2007
    ..To evaluate the association between inflammatory status, as measured by C-reactive protein (CRP), during inpatient admission and subsequent inpatient outcome and associated resource use...
  56. ncbi Modelling lifetime metabolic progression and cost effectiveness of treatment strategies for type 2 diabetes
    Andrew J Palmer
    Pharmacoeconomics 24:927-9; author reply 929-35. 2006
  57. ncbi CHKS data should be avoided when investigating mortality
    Craig J Currie
    Respir Med 102:172. 2008
  58. ncbi Randomized single versus double embryo transfer studies: obstetric and paediatric outcome and a cost-effectiveness analysis
    Craig J Currie
    Hum Reprod 21:1939-40; author reply 1940-1. 2006